CONDENSED CONSOLIDATED BALANCE SHEET - Unaudited - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents ($509 and $630 related to VIEs)	$ 1,913	$ 2,209
Marketable securities ($166 and $90 related to VIEs)	203	127
Accounts receivable, net ($171 and $173 related to VIEs)	998	1,171
Contract assets	1,011	1,066
Other current assets ($34 and $28 related to VIEs)	432	608
Total current assets	4,557	5,181
Noncurrent assets
PP&E, net ($47 and $46 related to VIEs)	501	456
Investments	543	517
Deferred taxes	55	51
Deferred compensation trusts	267	330
Goodwill	251	249
Other assets ($44 and $45 related to VIEs)	318	305
Total noncurrent assets	1,935	1,908
Total assets	6,492	7,089
Current liabilities
Accounts payable ($266 and $261 related to VIEs)	1,002	1,220
Short-term borrowings	214	18
Contract liabilities ($308 and $351 related to VIEs)	805	945
Accrued salaries, wages and benefits ($21 and $27 related to VIEs)	580	629
Other accrued liabilities ($37 and $33 related to VIEs)	594	802
Total current liabilities	3,195	3,614
Long-term debt	982	1,174
Deferred taxes	70	67
Other noncurrent liabilities ($13 related to VIEs in both periods)	600	667
Contingencies and commitments
Shareholders’ equity
Preferred stock — authorized 20,000,000 shares ($0.01 par value); issued and outstanding —600,000 shares in 2022 and 2021	0	0
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 142,008,804 and 141,434,771 shares in 2022 and 2021, respectively	1	1
Additional paid-in capital	976	967
AOCI	(337)	(366)
Retained earnings	829	791
Total shareholders’ equity	1,469	1,393
NCI	176	174
Total equity	1,645	1,567
Total liabilities and equity	$ 6,492	$ 7,089